Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amzole India
Udaipur, Rajasthan, India
- Ownership
- Private
- Development stage
- Other
01
Overview
Amzole India is an Indian specialty chemicals and pharma-intermediates manufacturer based in Udaipur, Rajasthan. The company appears to be focused on commercial-scale production of glyoxal-40%, 2-methyl imidazole, 2-methyl-5-nitroimidazole, glyoxylic acid, and related industrial and drug intermediates rather than on innovative therapeutics. Its website positions it as one of the largest Indian manufacturers of glyoxal-40%, with exports to Indian and international markets. Amzole India therefore looks more like a manufacturing-led chemicals/pharma supply company than a clinical-stage biotech or branded pharmaceutical developer.
- Modalities
- Small molecule
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on Amzole India.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amzole India.